» Articles » PMID: 34355454

Recall of Genomic Testing Results Among Patients with Cancer

Overview
Journal Oncologist
Specialty Oncology
Date 2021 Aug 6
PMID 34355454
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Genomic testing of somatic and germline DNA has transformed cancer care. However, low genetic knowledge among patients may compromise care and health outcomes. Given the rise in genomic testing, we sought to understand patients' knowledge of their genetic test results.

Materials And Methods: We conducted a survey-based study with 85 patients at a comprehensive cancer center. We compared self-reported recall of (a) having had somatic/germline testing and (b) their specific somatic/germline results to the genomic test results documented in the medical record.

Results: Approximately 30% of patients did not recall having had testing. Of those who recalled having testing, 44% of patients with pathogenic/likely pathogenic germline mutations and 57% of patients with reported somatic alterations did not accurately recall their specific gene or variant-level results.

Conclusion: Given significant knowledge gaps in patients' recall of genomic testing, there is a critical need to improve patient-directed education and return-of-results strategies.

Citing Articles

Exploring Literacy and Knowledge Gaps and Disparities in Genetics and Oncogenomics Among Cancer Patients and the General Population: A Scoping Review.

Nikitara K, Cardoso M, Vicente A, Batalha Silva Rasga C, De Angelis R, Chamoun Morel Z Healthcare (Basel). 2025; 13(2).

PMID: 39857147 PMC: 11765264. DOI: 10.3390/healthcare13020121.


What Do Patients With Cancer Know, or Want to Know, About Genomic Tumor Sequencing and Genetic Testing? A State-of-the-Art Review.

Stewart L, Ward L J Adv Pract Oncol. 2025; 1-14.

PMID: 39802538 PMC: 11715401. DOI: 10.6004/jadpro.2024.15.8.14.


Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting.

Stackland S, Schnabel D, Dinan M, Dinan M, Presley C, Gross C J Natl Cancer Inst. 2024; 117(1):144-151.

PMID: 39288939 PMC: 11717411. DOI: 10.1093/jnci/djae196.


Patient survey on cancer genomic medicine in Japan under the national health insurance system.

Kage H, Akiyama N, Chang H, Shinozaki-Ushiku A, Ka M, Kawata J Cancer Sci. 2024; 115(3):954-962.

PMID: 38273803 PMC: 10920978. DOI: 10.1111/cas.16065.


Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.

Bednar E, Rauh-Hain J, Garcia J, de Aguinaga N, Anne Powell M, Peral S Cancer Prev Res (Phila). 2023; 17(1):19-28.

PMID: 37913800 PMC: 10872900. DOI: 10.1158/1940-6207.CAPR-23-0303.


References
1.
Langer M, Roche M, Brewer N, Berg J, Khan C, Leos C . Development and Validation of a Genomic Knowledge Scale to Advance Informed Decision Making Research in Genomic Sequencing. MDM Policy Pract. 2018; 2(1). PMC: 6005662. DOI: 10.1177/2381468317692582. View

2.
Blanchette P, Spreafico A, Miller F, Chan K, Bytautas J, Kang S . Genomic testing in cancer: patient knowledge, attitudes, and expectations. Cancer. 2014; 120(19):3066-73. DOI: 10.1002/cncr.28807. View

3.
Freedman R, Kouri E, West D, Keating N . Racial/ethnic disparities in knowledge about one's breast cancer characteristics. Cancer. 2015; 121(5):724-32. PMC: 4946569. DOI: 10.1002/cncr.28977. View

4.
Molster C, Charles T, Samanek A, OLeary P . Australian study on public knowledge of human genetics and health. Public Health Genomics. 2008; 12(2):84-91. DOI: 10.1159/000164684. View

5.
Lacour R, Daniels M, Westin S, Meyer L, Burke C, Burns K . What women with ovarian cancer think and know about genetic testing. Gynecol Oncol. 2008; 111(1):132-6. PMC: 3746752. DOI: 10.1016/j.ygyno.2008.06.016. View